# Unveiling tissue-specific transcriptional adaptations in iPSC-derived fibroblasts via co-culture systems

**Authors:** Amar J. Azad, Alessandro Bentivogli, Henrike Germar, Dana Wörz, Elena Lizunova, Max J. Cumberland, January Weiner, Sarah Hedtrich

PMC · DOI: 10.1186/s13287-025-04537-6 · Stem Cell Research & Therapy · 2025-07-30

## TL;DR

This study shows that iPSC-derived fibroblasts can adapt their gene activity to mimic tissue-specific traits when co-cultured with other cell types, but these changes are often incomplete and temporary.

## Contribution

The study demonstrates that iFBs can acquire tissue-specific transcriptional profiles through co-culture, revealing their potential for disease modeling.

## Key findings

- iFBs showed transcriptional plasticity, adapting to co-culture environments across all germ layers.
- Paracrine signaling induced transient changes, while sustained interactions led to stable adaptations.
- Pathway analysis revealed TGF-β activation in cardiac iFBs and ECM remodelling in dermal iFBs.

## Abstract

Induced pluripotent stem cell-derived fibroblasts (iFBs) hold promise for autologous disease modelling, but their ability to replicate tissue-specific fibroblast characteristics remains unclear. Fibroblasts exhibit significant heterogeneity, with distinct subtypes playing critical roles in organ function and integrity. This study investigates whether iFBs can acquire tissue-specific transcriptional profiles through co-culture with cells from different germ layers, including skin (keratinocytes), heart (cardiomyocytes), gut (intestinal cells), and lung (bronchial epithelial cells).

iFBs were co-cultured directly or indirectly with organ-specific cell types, followed by bulk RNA sequencing and pathway analysis. Transcriptional profiles were compared to primary fibroblasts using principal component analysis (PCA), large single-cell databases of over 20,000 cells for single-cell deconvolution and targeted qPCR validation. Statistical significance was assessed via one-way ANOVA.

Transcriptomic analysis revealed that iFBs exhibit transcriptional plasticity, adopting molecular phenotypes aligned with their co-culture environment across all germ layers. Paracrine signalling induced transient tissue-specific changes in indirectly co-cultured iFBs, but sustained interactions were required for stable adaptations. Pathway analysis highlighted functional shifts, such as TGF-β activation in cardiac iFBs and ECM remodelling in dermal iFBs. However, single-cell deconvolution showed incomplete tissue specification, with iFBs retaining mixed fibroblast subpopulations.

These findings demonstrate that iFBs can adopt tissue-specific transcriptional profiles, supporting their potential for modelling fibrotic microenvironments in 3D in vitro systems. However, the partial and transient nature of these adaptations underscores the need to validate whether transcriptional changes translate to functional fibroblast behaviours, such as ECM dysregulation or aberrant TGF-β signalling, in complex tissue models. Optimising co-culture conditions to stabilise these phenotypes will be critical for leveraging iFBs in fibrosis research, drug screening, and personalised disease modelling.

The online version contains supplementary material available at 10.1186/s13287-025-04537-6.

## Linked entities

- **Proteins:** TGFB1 (transforming growth factor beta 1)

## Full-text entities

- **Genes:** WNT7A (Wnt family member 7A) [NCBI Gene 7476] {aka SANTOS, Wnt-7a}, PDGFRA (platelet derived growth factor receptor alpha) [NCBI Gene 5156] {aka CD140A, PDGFR-2, PDGFR2}, BMP4 (bone morphogenetic protein 4) [NCBI Gene 652] {aka BMP2B, BMP2B1, MCOPS6, OFC11, ZYME}, SOX17 (SRY-box transcription factor 17) [NCBI Gene 64321] {aka PPH7, VUR3}, NOG (noggin) [NCBI Gene 9241] {aka SYM1, SYNS1, SYNS1A}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, Hhip (Hedgehog-interacting protein) [NCBI Gene 15245] {aka Hhip1}, NPNT (nephronectin) [NCBI Gene 255743] {aka EGFL6L, POEM}, VIM (vimentin) [NCBI Gene 7431], FGF2 (fibroblast growth factor 2) [NCBI Gene 2247] {aka BFGF, FGF-2, FGFB, HBGF-2}, LGR5 (leucine rich repeat containing G protein-coupled receptor 5) [NCBI Gene 8549] {aka FEX, GPR49, GPR67, GRP49, HG38}, POU5F1 (POU class 5 homeobox 1) [NCBI Gene 5460] {aka OCT3, OCT4, OCT4Borf1, OTF-3, OTF3, OTF4}, EGF (epidermal growth factor) [NCBI Gene 1950] {aka HOMG4, URG}, MMP2 (matrix metallopeptidase 2) [NCBI Gene 4313] {aka CLG4, CLG4A, MMP-2, MMP-II, MONA, TBE-1}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, KRT14 (keratin 14) [NCBI Gene 3861] {aka CK14, EBS1, EBS1A, EBS1B, EBS1C, EBS1D}, CXCL12 (C-X-C motif chemokine ligand 12) [NCBI Gene 6387] {aka IRH, PBSF, SCYB12, SDF1, TLSF, TPAR1}, CTHRC1 (collagen triple helix repeat containing 1) [NCBI Gene 115908], FBLN1 (fibulin 1) [NCBI Gene 2192] {aka FBLN, FIBL1}, Postn (periostin, osteoblast specific factor) [NCBI Gene 50706] {aka A630052E07Rik, OSF-2, Osf2, PLF, PN}, RSPO3 (R-spondin 3) [NCBI Gene 84870] {aka CRISTIN1, PWTSR, THSD2}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, IGF1 (insulin like growth factor 1) [NCBI Gene 3479] {aka IGF, IGF-I, IGFI, MGF}, NANOG (Nanog homeobox) [NCBI Gene 79923], Tbx20 (T-box 20) [NCBI Gene 57246] {aka 9430010M06Rik, Tbx12}, ACTA1 (actin alpha 1, skeletal muscle) [NCBI Gene 58] {aka ACTA, ASMA, CFTD, CFTD1, CFTDM, CMYO2A}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, MRAP (melanocortin 2 receptor accessory protein) [NCBI Gene 56246] {aka B27, C21orf61, FALP, GCCD2, MRAP1}
- **Diseases:** inflammation (MESH:D007249), fibrosis (MESH:D005355), infectious disease (MESH:D003141), pulmonary fibrosis (MESH:D011658)
- **Chemicals:** Penicillin (MESH:D010406), GlutaMAX (MESH:C054122), Prostaglandin E2 (MESH:D015232), L-ascorbic acid (MESH:D001205), Y (MESH:D015019), HEPES (MESH:D006531), PBS (MESH:D007854), Calcium (MESH:D002118), EDTA (MESH:D004492), DMEM (-), CO2 (MESH:D002245), L-glutamine (MESH:D005973), A83-01 (MESH:C507011), Streptomycin (MESH:D013307), polyA (MESH:D011061), SYBR Green I (MESH:C098022), agarose (MESH:D012685), CHIR99021 (MESH:C473711), Y-27632 (MESH:C108830)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** BIHi005- — Homo sapiens (Human), Induced pluripotent stem cell (CVCL_IT56), fibroblasts — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0594), NHBE — Rattus norvegicus (Rat), Spontaneously immortalized cell line (CVCL_AR51), CnT-PR-F — Homo sapiens (Human), Osteosarcoma, Cancer cell line (CVCL_A5LV)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12312452/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12312452/full.md

## References

6 references — full list in the complete paper: https://tomesphere.com/paper/PMC12312452/full.md

---
Source: https://tomesphere.com/paper/PMC12312452